Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

140 results about "Molecular model" patented technology

A molecular model, in this article, is a physical model that represents molecules and their processes. The creation of mathematical models of molecular properties and behaviour is molecular modelling, and their graphical depiction is molecular graphics, but these topics are closely linked and each uses techniques from the others. In this article, "molecular model" will primarily refer to systems containing more than one atom and where nuclear structure is neglected. The electronic structure is often also omitted or represented in a highly sophisticated way.

Point kernel integration method and Monte Carlo method coupling-based radiation shielding calculation method

The invention relates to the technical field of nuclear radiation protection, and provides a point kernel integration method and Monte Carlo method coupling-based radiation shielding calculation method. The method comprises the steps of establishing a geometric part of a point kernel integration sub-model; establishing a source item part of the point kernel integration sub-model, and performing discrete processing on a body source or a surface source; solving attenuation of the source item in the point kernel integration sub-model; solving a wide beam accumulation factor; solving a point kernel integration equation to obtain the dosage rate or the flux density of a shielding region; according to variable parameters provided by a user, performing iterative calculation; comparing all geometric information obtained by calculation with the dosage rate / the flux result to obtain an optimal model meeting the demand; according to the optimal model, building a Monte Carlo sub-model; solving theMonte Carlo sub-model by using a Monte Carlo calculation program; and comparing calculation results of the Monte Carlo sub-model and the point kernel integration sub-model. According to the calculation method, the calculation correctness can be assessed during the iterative calculation, so that the calculation precision is improved and relatively high calculation efficiency can be achieved.
Owner:NO 719 RES INST CHINA SHIPBUILDING IND

Esophageal squamous cell carcinoma autoantibody molecular marker model and application thereof

The invention relates to an esophageal squamous cell carcinoma autoantibody molecular marker model and an application thereof. The molecular model mainly comprises an ALDOA autoantibody, an ENO1 autoantibody, a p53 autoantibody, and an NY-ESO-1 autoantibody, and can be used for preparing a kit for distinguishing esophageal squamous carcinoma patients and healthy medical examiners. The kit for detecting esophageal squamous cell carcinoma patients mainly comprises recombinant ALDOAD protein, recombinant ENO1 protein, recombinant p53 protein, and recombinant NY-ESO-1 protein. According to the esophageal squamous cell carcinoma autoantibody molecular marker model and the application thereof, the ENO1 autoantibody is found to be elevated in serum level in the esophageal squamous carcinoma patients for the first time, and is jointly detected with the ALDOA autoantibody, the p53 autoantibody, and the NY-ESO-1 autoantibody for distinguishing the esophageal squamous cell carcinoma patients andthe healthy medical examiners, and has a better distinguishing effect than a single index detection; and in addition, the detection method adopted by the invention is an enzyme-linked immunosorbent assay indirect method, is simple and convenient to implement, has good sensitivity and specificity, and is a method which is mature and reliable and can be widely used in base layer hospitals.
Owner:汕头市颂美恩生物科技有限公司

Method and system of product development process for chemical compositions using high volume modeling

A method and system of transforming a product development process to reduce time in bringing a product to market through high throughput experimentation and advanced statistics and informatics, to transform the product development to a level of higher correlation with engine tests, and to develop better commercial products. This is achieved by modeling in Silico a plurality of component molecular models; deriving in Silico molecular characteristics (descriptors) for each of the plurality of compiled molecular models; creating at least one combinatorial library database record for each of the formulations, the at least one record having a plurality fields for storing information about compositional characteristics; receiving specification requirements for a lubricating oil composition; selecting from a database entries corresponding to compositions having specifications comparable to the received specification requirements; formulating a new lubricating oil composition to comply with received specification requirements; testing the new lubricant oil for compliance with received specification requirements; repeating the selecting, formulating, and testing steps until compliance with received specification requirements is achieved; and correlating the new lubricating oil composition to actual engine performance.
Owner:CHEVRON ORONITE CO LLC

Synthesis method of polypeptide-nanogold particle drug carrier

Belonging to the technical fields of biomedical materials and nanotechnologies, the invention discloses a synthesis method of a polypeptide-nanogold particle drug carrier. A drug delivery system comprises polypeptide modified nanogold particles and a drug molecular model encapsulated therein, or in other words, the nanogold particles are modified by polypeptide molecules on them so as to prepare the nanogold particle drug delivery system. By adjusting the proportions of stable polypeptides and functional polypeptides in an initial reaction mixture, polypeptide-nanogold carriers with different packaging abilities can be obtained. Experiments prove that, the method has the advantages of simple operation and less time consumption, and has a very good cell delivery effect on the drug molecular model. The drug carrier synthesized by the method has good biocompatibility and small toxic and side effect in organisms, thus being applicable to cancer treatment.
Owner:CHANGZHOU UNIV

Grid-based computational chemistry application integrated system

The invention discloses a grid-based computational chemistry application integrated system, which comprises distributed chemical resource modules, a grid middleware module and an operation interface module. The chemical resource modules are distributed at different grid nodes and include computing resources provided with computational chemistry application software and chemistry knowledge units with conceptions and methods relative to the chemistry field. The grid middleware module realizes share and collaboration of resources, forms a computing platform having performance higher than that of the single machine, and comprises a service interface unit, an operation dispatching unit and a knowledge base unit. The operation interface module comprises a molecular modeling unit for transforming molecular models into data structures inside computers, a molecular visualization unit for displaying three-dimensional structure of molecules, an operation managing unit for assisting users to submit operations to the grid and monitoring, operating and downloading the operations, and a management community unit. Molecular modeling, visualization, computing and result acquisition can be realized for users by the system, so that the users enjoy the convenient one-stop service.
Owner:COMP NETWORK INFORMATION CENT CHINESE ACADEMY OF SCI

Estimation of Conductivity for Nanoporous Materials

Methods and systems for estimating conductivity of clay mineral systems, and for applying the estimates in larger-scale analysis. Conductivity of the clay may be estimated by constructing a molecular model of an anhydrous charge-neutral clay, and then assigning a charge density by substitution of ions in the model of the clay structure. Counterions are inserted for charge neutrality, and water molecules are added to the model to reflect a selected level of hydration. Following assignment of force-field coefficients, molecular dynamics simulation provides data from which diffusion coefficients can be estimated. Application of the Nernst-Einstein relationship to the diffusion coefficients of the counterions provides the ion conductivity of the clay system. This conductivity can be used to derive a formation factor, and can be applied in direct numerical simulation analysis.
Owner:BP CORP NORTH AMERICA INC

Kit for distinguishing colorectal adenomas from colorectal cancer

The invention discloses a kit for distinguishing colorectal adenomas from colorectal cancer. The kit for distinguishing or assisting in distinguishing the colorectal adenomas from the colorectal cancer comprises a device for detecting phospholipids content and a contrast card established by the phospholipids content, wherein phospholipids are sphingosylphosphorylcholine (SPC), 16:0 sphingomyelin (SM), 18:0SM, 14:0 lysophosphatidylcholine (LPC), 16:0LPC, 18:0LPC, 20:0LPC and 22:0LPC. Saturated LPC, SPC and SM are taken as markers, and a molecular model for distinguishing the colorectal adenomas from the colorectal cancer is established, and has colorectal cancer distinguishing sensitivity of 90 percent and colorectal cancer distinguishing specificity of 93 percent.
Owner:BEIJING NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products